Our lab, following Bernardoni et al., used transgenic flies harboring the full human BCR-ABL1 fusion protein to further explore the use of fruit flies both as a genetic or drug screening model for CML. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.